BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Akao Y, Mizoguchi H, Kojima S, Naoe T, Ohishi N, Yagi K. Arsenic induces apoptosis in B-cell leukaemic cell lines in vitro: activation of caspases and down-regulation of Bcl-2 protein. Br J Haematol. 1998;102:1055-1060. [PMID: 9734658 DOI: 10.1046/j.1365-2141.1998.00869.x] [Cited by in Crossref: 103] [Cited by in F6Publishing: 106] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Veas IP. Arsenic binding proteins in cardiovascular human tissues. JCCR 2021;14:137-143. [DOI: 10.15406/jccr.2021.14.00530] [Reference Citation Analysis]
2 Olivas-Aguirre M, Pottosin I, Dobrovinskaya O. Mitochondria as emerging targets for therapies against T cell acute lymphoblastic leukemia. J Leukoc Biol 2019;105:935-46. [PMID: 30698851 DOI: 10.1002/JLB.5VMR0818-330RR] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
3 Feng Y, Jurisson SS. Trithiol compounds—tricky but valuable: the design and synthesis of ligands for stabilizing radioarsenic for radiopharmaceutical development. Strategies and Tactics in Organic Synthesis 2019. [DOI: 10.1016/b978-0-12-814805-1.00008-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Kumar S, Farah IO, Tchounwou PB. Trisenox induces cytotoxicity through phosphorylation of mitogen-activated protein kinase molecules in acute leukemia cells. J Biochem Mol Toxicol 2018;32:e22207. [PMID: 30091188 DOI: 10.1002/jbt.22207] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Sage AP, Minatel BC, Ng KW, Stewart GL, Dummer TJB, Lam WL, Martinez VD. Oncogenomic disruptions in arsenic-induced carcinogenesis. Oncotarget 2017;8:25736-55. [PMID: 28179585 DOI: 10.18632/oncotarget.15106] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 8.0] [Reference Citation Analysis]
6 Attreed SE, Navas-Acien A, Heaney CD. Arsenic and Immune Response to Infection During Pregnancy and Early Life. Curr Environ Health Rep 2017;4:229-43. [PMID: 28488132 DOI: 10.1007/s40572-017-0141-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
7 Degraffenreid AJ, Feng Y, Wycoff DE, Morrow R, Phipps MD, Cutler CS, Ketring AR, Barnes CL, Jurisson SS. Dithiol Aryl Arsenic Compounds as Potential Diagnostic and Therapeutic Radiopharmaceuticals. Inorg Chem 2016;55:8091-8. [DOI: 10.1021/acs.inorgchem.6b01175] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
8 Wu S, Xu L, Huang X, Geng S, Xu Y, Chen S, Yang L, Wu X, Weng J, DU X, Li Y. Arsenic induced complete remission in a refractory T-ALL patient with a distinct T-cell clonal evolution without molecular complete remission: A case report. Oncol Lett 2016;11:4123-30. [PMID: 27313752 DOI: 10.3892/ol.2016.4529] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
9 Dixit S, Dhar P, Mehra RD. Alpha lipoic acid (ALA) modulates expression of apoptosis associated proteins in hippocampus of rats exposed during postnatal period to sodium arsenite (NaAsO2). Toxicol Rep 2015;2:78-87. [PMID: 28962340 DOI: 10.1016/j.toxrep.2015.01.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
10 Gera R, Singh V, Sharma AK, Ghosh D. Immunomodulation by Environmental Chemicals. Advances in Molecular Toxicology 2015. [DOI: 10.1016/b978-0-12-802229-0.00004-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 Ser PH, Banu B, Jebunnesa F, Fatema K, Rosy N, Yasmin R, Furusawa H, Ali L, Ahmad SA, Watanabe C. Arsenic exposure increases maternal but not cord serum IgG in Bangladesh. Pediatr Int 2015;57:119-25. [PMID: 24862852 DOI: 10.1111/ped.12396] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
12 Song LL, Tu YY, Xia L, Wang WW, Wei W, Ma CM, Wen DH, Lei H, Xu HZ, Wu YL. Targeting catalase but not peroxiredoxins enhances arsenic trioxide-induced apoptosis in K562 cells. PLoS One 2014;9:e104985. [PMID: 25115845 DOI: 10.1371/journal.pone.0104985] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
13 Aldoss I, Mark L, Vrona J, Ramezani L, Weitz I, Mohrbacher AM, Douer D. Adding ascorbic acid to arsenic trioxide produces limited benefit in patients with acute myeloid leukemia excluding acute promyelocytic leukemia. Ann Hematol 2014;93:1839-43. [PMID: 24906216 DOI: 10.1007/s00277-014-2124-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
14 Kumar S, Yedjou CG, Tchounwou PB. Arsenic trioxide induces oxidative stress, DNA damage, and mitochondrial pathway of apoptosis in human leukemia (HL-60) cells. J Exp Clin Cancer Res 2014;33:42. [PMID: 24887205 DOI: 10.1186/1756-9966-33-42] [Cited by in Crossref: 83] [Cited by in F6Publishing: 92] [Article Influence: 10.4] [Reference Citation Analysis]
15 Ma ZB, Xu HY, Jiang M, Yang YL, Liu LX, Li YH. Arsenic trioxide induces apoptosis of human gastrointestinal cancer cells. World J Gastroenterol 2014; 20(18): 5505-5510 [PMID: 24833880 DOI: 10.3748/wjg.v20.i18.5505] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
16 Roszak J, Smok-Pieniążek A, Nocuń M, Stępnik M. Characterization of arsenic trioxide resistant clones derived from Jurkat leukemia T cell line: focus on PI3K/Akt signaling pathway. Chem Biol Interact 2013;205:198-211. [PMID: 23911876 DOI: 10.1016/j.cbi.2013.07.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
17 Garnier N, Petruccelli LA, Molina MF, Kourelis M, Kwan S, Diaz Z, Schipper HM, Gupta A, del Rincon SV, Mann KK, Miller WH Jr. The novel arsenical Darinaparsin circumvents BRG1-dependent, HO-1-mediated cytoprotection in leukemic cells. Leukemia 2013;27:2220-8. [PMID: 23426167 DOI: 10.1038/leu.2013.54] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
18 Cheng J, Wei H, Chen J, Xie B. Antitumor effect of arsenic trioxide in human K562 and K562/ADM cells by autophagy. Toxicology Mechanisms and Methods 2012;22:512-9. [DOI: 10.3109/15376516.2012.686534] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
19 Zhang D, Huang C. Apoptotic Pathways upon Arsenite Treatment. Novel Apoptotic Regulators in Carcinogenesis 2012. [DOI: 10.1007/978-94-007-4917-7_6] [Reference Citation Analysis]
20 Sun H, Zhang S. Arsenic trioxide regulates the apoptosis of glioma cell and glioma stem cell via down-regulation of stem cell marker Sox2. Biochem Biophys Res Commun. 2011;410:692-697. [PMID: 21703238 DOI: 10.1016/j.bbrc.2011.06.060] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
21 Habib GM. Arsenite causes down-regulation of Akt and c-Fos, cell cycle dysfunction and apoptosis in glutathione-deficient cells. J Cell Biochem 2010;110:363-71. [PMID: 20336670 DOI: 10.1002/jcb.22548] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
22 Yedjou C, Tchounwou P, Jenkins J, McMurray R. Basic mechanisms of arsenic trioxide (ATO)-induced apoptosis in human leukemia (HL-60) cells. J Hematol Oncol 2010;3:28. [PMID: 20796291 DOI: 10.1186/1756-8722-3-28] [Cited by in Crossref: 56] [Cited by in F6Publishing: 63] [Article Influence: 4.7] [Reference Citation Analysis]
23 Ge F, Lu XP, Zeng HL, He QY, Xiong S, Jin L, He QY. Proteomic and functional analyses reveal a dual molecular mechanism underlying arsenic-induced apoptosis in human multiple myeloma cells. J Proteome Res 2009;8:3006-19. [PMID: 19364129 DOI: 10.1021/pr9001004] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 3.5] [Reference Citation Analysis]
24 Momeny M, Zakidizaji M, Ghasemi R, Dehpour AR, Rahimi-Balaei M, Abdolazimi Y, Ghavamzadeh A, Alimoghaddam K, Ghaffari SH. Arsenic trioxide induces apoptosis in NB-4, an acute promyelocytic leukemia cell line, through up-regulation of p73 via suppression of nuclear factor kappa B-mediated inhibition of p73 transcription and prevention of NF-kappaB-mediated induction of XIAP, cIAP2, BCL-XL and survivin. Med Oncol 2010;27:833-42. [PMID: 19763917 DOI: 10.1007/s12032-009-9294-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
25 Sahara N, Takeshita A, Kobayashi M, Shigeno K, Nakamura S, Shinjo K, Naito K, Maekawa M, Horii T, Ohnishi K, Kitamura K, Naoe T, Hayashi H, Ohno R. Phenylarsine Oxide (PAO) More Intensely Induces Apoptosis in Acute Promyelocytic Leukemia and As 2 O 3 -Resistant APL Cell Lines than As 2 O 3 by Activating the Mitochondrial Pathway. Leukemia & Lymphoma 2009;45:987-95. [DOI: 10.1080/10428190310001617222] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
26 Yin W, Li X, Feng S, Cheng W, Tang B, Shi Y, Hua Z. Plasma membrane depolarization and Na,K-ATPase impairment induced by mitochondrial toxins augment leukemia cell apoptosis via a novel mitochondrial amplification mechanism. Biochemical Pharmacology 2009;78:191-202. [DOI: 10.1016/j.bcp.2009.03.025] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
27 Huang M, Hsieh R, Lin C, Chang IY, Liu H. The Cytotoxicity of Arsenic Trioxide to Normal Hematopoietic Progenitors and Leukemic Cells is Dependent on Their Cell-cycle Status. Leukemia & Lymphoma 2009;43:2191-9. [DOI: 10.1080/1042819021000032980] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
28 Cosenza M, Civallero M, Sacchi S, Marcheselli R, Pozzi S. Biological effects of Atra and Arsenic Trioxide on short term cultures of non-M3 leukemic blasts. Leukemia & Lymphoma 2009;46:257-63. [DOI: 10.1080/10428190400014991] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
29 Huang S, Yang C, Chen Y. Arsenic Trioxide Therapy for Relapsed Acute Promyelocytic Leukemia: an Useful Salvage Therapy. Leukemia & Lymphoma 2009;38:283-93. [DOI: 10.3109/10428190009087019] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
30 Bachleitner-hofmann T, Kees M, Gisslinger H. Arsenic Trioxide: Acute Promyelocytic Leukemia and Beyond. Leukemia & Lymphoma 2009;43:1535-40. [DOI: 10.1080/1042819021000002857] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
31 Ho S, Chen W, Chiu H, Lai C, Guo H, Wang Y. Combination treatment with arsenic trioxide and irradiation enhances apoptotic effects in U937 cells through increased mitotic arrest and ROS generation. Chemico-Biological Interactions 2009;179:304-13. [DOI: 10.1016/j.cbi.2008.12.015] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
32 Chang JE, Voorhees PM, Kolesar JM, Ahuja HG, Sanchez FA, Rodriguez GA, Kim K, Werndli J, Bailey HH, Kahl BS. Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: a Wisconsin Oncology Network study. Hematol Oncol 2009;27:11-6. [PMID: 18668698 DOI: 10.1002/hon.870] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
33 Platanias LC. Biological responses to arsenic compounds. J Biol Chem 2009;284:18583-7. [PMID: 19363033 DOI: 10.1074/jbc.R900003200] [Cited by in Crossref: 117] [Cited by in F6Publishing: 120] [Article Influence: 9.0] [Reference Citation Analysis]
34 Bairey O, Vanichkin A, Shpilberg O. Arsenic-trioxide-induced apoptosis of chronic lymphocytic leukemia cells. Int J Lab Hematol 2010;32:e77-85. [PMID: 19208092 DOI: 10.1111/j.1751-553X.2008.01134.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
35 Carney DA. Arsenic trioxide mechanisms of action--looking beyond acute promyelocytic leukemia. Leuk Lymphoma 2008;49:1846-51. [PMID: 18949607 DOI: 10.1080/10428190802464745] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
36 Franco R, Sánchez-Olea R, Reyes-Reyes EM, Panayiotidis MI. Environmental toxicity, oxidative stress and apoptosis: ménage à trois. Mutat Res. 2009;674:3-22. [PMID: 19114126 DOI: 10.1016/j.mrgentox.2008.11.012] [Cited by in Crossref: 351] [Cited by in F6Publishing: 360] [Article Influence: 25.1] [Reference Citation Analysis]
37 Wu Y, Yen W, Yih L. Requirement of a functional spindle checkpoint for arsenite-induced apoptosis. J Cell Biochem 2008;105:678-87. [DOI: 10.1002/jcb.21861] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
38 Ben Zirar S, Astier A, Muchow M, Gibaud S. Comparison of nanosuspensions and hydroxypropyl-β-cyclodextrin complex of melarsoprol: Pharmacokinetics and tissue distribution in mice. European Journal of Pharmaceutics and Biopharmaceutics 2008;70:649-56. [DOI: 10.1016/j.ejpb.2008.05.012] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
39 Diaz Z, Mann KK, Marcoux S, Kourelis M, Colombo M, Komarnitsky PB, Miller WH Jr. A novel arsenical has antitumor activity toward As2O3-resistant and MRP1/ABCC1-overexpressing cell lines. Leukemia 2008;22:1853-63. [PMID: 18633430 DOI: 10.1038/leu.2008.194] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
40 Pei B, Wang S, Guo X, Wang J, Yang G, Hang H, Wu L. Arsenite-Induced Germline Apoptosis through a MAPK-Dependent, p53-independent Pathway in Caenorhabditis elegans. Chem Res Toxicol 2008;21:1530-5. [DOI: 10.1021/tx800074e] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
41 Tarhini AA, Kirkwood JM, Tawbi H, Gooding WE, Islam MF, Agarwala SS. Safety and efficacy of arsenic trioxide for patients with advanced metastatic melanoma. Cancer 2008;112:1131-8. [PMID: 18286511 DOI: 10.1002/cncr.23284] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
42 Dolniak B, Katsoulidis E, Carayol N, Altman JK, Redig AJ, Tallman MS, Ueda T, Watanabe-Fukunaga R, Fukunaga R, Platanias LC. Regulation of arsenic trioxide-induced cellular responses by Mnk1 and Mnk2. J Biol Chem 2008;283:12034-42. [PMID: 18299328 DOI: 10.1074/jbc.M708816200] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
43 Nohara K, Ao K, Miyamoto Y, Suzuki T, Imaizumi S, Tateishi Y, Omura S, Tohyama C, Kobayashi T. Arsenite-Induced Thymus Atrophy is Mediated by Cell Cycle Arrest: A Characteristic Downregulation of E2F-Related Genes Revealed by a Microarray Approach. Toxicological Sciences 2008;101:226-38. [DOI: 10.1093/toxsci/kfm268] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
44 Campbell RA, Sanchez E, Steinberg JA, Baritaki S, Gordon M, Wang C, Shalitin D, Chen H, Pang S, Bonavida B, Said J, Berenson JR. Antimyeloma effects of arsenic trioxide are enhanced by melphalan, bortezomib and ascorbic acid. Br J Haematol 2007;138:467-78. [DOI: 10.1111/j.1365-2141.2007.06675.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.5] [Reference Citation Analysis]
45 Peng Z, Peng L, Fan Y, Zandi E, Shertzer HG, Xia Y. A critical role for IkappaB kinase beta in metallothionein-1 expression and protection against arsenic toxicity. J Biol Chem 2007;282:21487-96. [PMID: 17526490 DOI: 10.1074/jbc.M702510200] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
46 Wang S, Zhao Y, Wu L, Tang M, Su C, Hei TK, Yu Z. Induction of germline cell cycle arrest and apoptosis by sodium arsenite in Caenorhabditis elegans. Chem Res Toxicol 2007;20:181-6. [PMID: 17305403 DOI: 10.1021/tx0601962] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 3.2] [Reference Citation Analysis]
47 Qian W, Liu J, Jin J, Ni W, Xu W. Arsenic trioxide induces not only apoptosis but also autophagic cell death in leukemia cell lines via up-regulation of Beclin-1. Leukemia Research 2007;31:329-39. [DOI: 10.1016/j.leukres.2006.06.021] [Cited by in Crossref: 148] [Cited by in F6Publishing: 156] [Article Influence: 9.9] [Reference Citation Analysis]
48 Berenson JR, Yeh HS. Arsenic Compounds in the Treatment of Multiple Myeloma: A New Role for a Historical Remedy. Clinical Lymphoma and Myeloma 2006;7:192-8. [DOI: 10.3816/clm.2006.n.058] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 2.6] [Reference Citation Analysis]
49 Jung HS, Kim HS, Lee MJ, Shin HY, Ahn HS, Ryu KH, Seoh JY, Kim CJ, Jang JJ. Arsenic trioxide concentration determines the fate of Ewing's sarcoma family tumors and neuroblastoma cells in vitro. FEBS Lett 2006;580:4969-75. [PMID: 16930595 DOI: 10.1016/j.febslet.2006.07.077] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
50 Ai Z, Lu W, Qin X. Arsenic trioxide induces gallbla-dder carcinoma cell apoptosis via downregulation of Bcl-2. Biochem Biophys Res Commun. 2006;348:1075-1081. [PMID: 16904648 DOI: 10.1016/j.bbrc.2006.07.181] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
51 Gibaud S, Alfonsi R, Mutzenhardt P, Fries I, Astier A. (2-Phenyl-[1,3,2]dithiarsolan-4-yl)-methanol derivatives show in vitro antileukemic activity. Journal of Organometallic Chemistry 2006;691:1081-4. [DOI: 10.1016/j.jorganchem.2005.11.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
52 Beer TM, Tangen CM, Nichols CR, Margolin KA, Dreicer R, Stephenson WT, Quinn DI, Raghavan D, Crawford ED. Southwest oncology group phase II study of arsenic trioxide in patients with refractory germ cell malignancies. Cancer 2006;106:2624-9. [DOI: 10.1002/cncr.21925] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
53 Tian X, Ma X, Qiao D, Ma A, Yan F, Huang X. mCICR is required for As2O3-induced permeability transition pore opening and cytochrome c release from mitochondria. Mol Cell Biochem 2005;277:33-42. [PMID: 16132712 DOI: 10.1007/s11010-005-4818-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
54 Han SS, Kim K, Hahm ER, Park CH, Kimler BF, Lee SJ, Lee SH, Kim WS, Jung CW, Park K, Kim J, Yoon SS, Lee JH, Park S. Arsenic trioxide represses constitutive activation of NF-kappaB and COX-2 expression in human acute myeloid leukemia, HL-60. J Cell Biochem 2005;94:695-707. [PMID: 15547942 DOI: 10.1002/jcb.20337] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 2.0] [Reference Citation Analysis]
55 Scholz C, Richter A, Lehmann M, Schulze-osthoff K, Dörken B, Daniel PT. Arsenic trioxide induces regulated, death receptor-independent cell death through a Bcl-2-controlled pathway. Oncogene 2005;24:7031-42. [DOI: 10.1038/sj.onc.1208868] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
56 Zheng Y, Yamaguchi H, Tian C, Lee MW, Tang H, Wang HG, Chen Q. Arsenic trioxide (As(2)O(3)) induces apoptosis through activation of Bax in hematopoietic cells. Oncogene 2005;24:3339-47. [PMID: 15735709 DOI: 10.1038/sj.onc.1208484] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 3.1] [Reference Citation Analysis]
57 Kimura A, Ishida Y, Wada T, Yokoyama H, Mukaida N, Kondo T. MRP-1 expression levels determine strain-specific susceptibility to sodium arsenic-induced renal injury between C57BL/6 and BALB/c mice. Toxicol Appl Pharmacol 2005;203:53-61. [PMID: 15694464 DOI: 10.1016/j.taap.2004.07.013] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.5] [Reference Citation Analysis]
58 Jønsson V, Gemmell CG, Wiik A. Emerging concepts in the management of the malignant haematological disorders. Expert Opinion on Pharmacotherapy 2005;1:713-35. [DOI: 10.1517/14656566.1.4.713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
59 Karasavvas N, Cárcamo JM, Stratis G, Golde DW. Vitamin C protects HL60 and U266 cells from arsenic toxicity. Blood 2005;105:4004-12. [PMID: 15677571 DOI: 10.1182/blood-2003-03-0772] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 2.5] [Reference Citation Analysis]
60 Scholz C, Wieder T, Stärck L, Essmann F, Schulze-osthoff K, Dörken B, Daniel PT. Arsenic trioxide triggers a regulated form of caspase-independent necrotic cell death via the mitochondrial death pathway. Oncogene 2005;24:1904-13. [DOI: 10.1038/sj.onc.1208233] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 3.6] [Reference Citation Analysis]
61 Park S, Han SS, Park CH, Hahm ER, Lee SJ, Park HK, Lee SH, Kim WS, Jung CW, Park K, Riordan HD, Kimler BF, Kim K, Lee JH. L-Ascorbic acid induces apoptosis in acute myeloid leukemia cells via hydrogen peroxide-mediated mechanisms. Int J Biochem Cell Biol 2004;36:2180-95. [PMID: 15313465 DOI: 10.1016/j.biocel.2004.04.005] [Cited by in Crossref: 66] [Cited by in F6Publishing: 66] [Article Influence: 3.9] [Reference Citation Analysis]
62 Lu D, Bai XC, Gui L, Su YC, Deng F, Liu B, Li XM, Zeng WS, Cheng BL, Luo SQ. Hydrogen peroxide in the Burkitt's lymphoma cell line Raji provides protection against arsenic trioxide-induced apoptosis via the phosphoinositide-3 kinase signalling pathway. Br J Haematol. 2004;125:512-520. [PMID: 15142122 DOI: 10.1111/j.1365-2141.2004.04940.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
63 Han S, Kim K, Hahm E, Lee SJ, Surh Y, Park HK, Kim WS, Jung CW, Lee MH, Park K, Yang J, Yoon S, Riordan NH, Riordan HD, Kimler BF, Park CH, Lee J, Park S. L-ascorbic acid represses constitutive activation of NF-?B and COX-2 expression in human acute myeloid leukemia, HL-60. J Cell Biochem 2004;93:257-70. [DOI: 10.1002/jcb.20116] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.0] [Reference Citation Analysis]
64 Thomas DA, Cortes J, Kantarjian HM. New agents in the treatment of acute lymphocytic leukaemia. Best Pract Res Clin Haematol 2002;15:771-90. [PMID: 12617876 DOI: 10.1053/beha.2003.0234] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
65 Kajiguchi T, Yamamoto K, Hossain K, Akhand AA, Nakashima I, Naoe T, Saito H, Emi N. Sustained activation of c-jun-terminal kinase (JNK) is closely related to arsenic trioxide-induced apoptosis in an acute myeloid leukemia (M2)-derived cell line, NKM-1. Leukemia 2003;17:2189-95. [DOI: 10.1038/sj.leu.2403120] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 1.7] [Reference Citation Analysis]
66 Sturlan S, Baumgartner M, Roth E, Bachleitner-hofmann T. Docosahexaenoic acid enhances arsenic trioxide–mediated apoptosis in arsenic trioxide–resistant HL-60 cells. Blood 2003;101:4990-7. [DOI: 10.1182/blood-2002-08-2391] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 3.4] [Reference Citation Analysis]
67 Dvorakova K, Payne CM, Landowski TH, Tome ME, Halperin DS, Dorr RT. Imexon activates an intrinsic apoptosis pathway in RPMI8226 myeloma cells: . Anti-Cancer Drugs 2002;13:1031-42. [DOI: 10.1097/00001813-200211000-00007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
68 Oketani M, Kohara K, Tuvdendorj D, Ishitsuka K, Komorizono Y, Ishibashi K, Arima T. Inhibition by arsenic trioxide of human hepatoma cell growth. Cancer Lett. 2002;183:147-153. [PMID: 12065089 DOI: 10.1016/s0304-3835(01)00800-x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 2.7] [Reference Citation Analysis]
69 Bode AM, Dong Z. The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects. Crit Rev Oncol Hematol. 2002;42:5-24. [PMID: 11923065 DOI: 10.1016/s1040-8428(01)00215-3] [Cited by in Crossref: 176] [Cited by in F6Publishing: 159] [Article Influence: 8.8] [Reference Citation Analysis]
70 Shim M, Kim H, Yang S, Lee I, Choi H, Kim T. Arsenic Trioxide Induces Apoptosis in Chronic Myelogenous Leukemia K562 Cells:Possible Involvement of p38 MAP Kinase. BMB Reports 2002;35:377-83. [DOI: 10.5483/bmbrep.2002.35.4.377] [Cited by in Crossref: 24] [Cited by in F6Publishing: 33] [Article Influence: 1.2] [Reference Citation Analysis]
71 Litzow MR. Acute lymphoblastic leukemia in adults. Curr Treat Options Oncol 2000;1:19-29. [PMID: 12057058 DOI: 10.1007/s11864-000-0012-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
72 Um S, Lee S, Kim E, Myoung J, Namkoong S, Park J. Down-regulation of human papillomavirus E6/E7 oncogene by arsenic trioxide in cervical carcinoma cells. Cancer Letters 2002;181:11-22. [DOI: 10.1016/s0304-3835(02)00039-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 1.3] [Reference Citation Analysis]
73 La Rosée P, Johnson K, O'dwyer ME, Druker BJ. In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia. Experimental Hematology 2002;30:729-37. [DOI: 10.1016/s0301-472x(02)00836-6] [Cited by in Crossref: 75] [Cited by in F6Publishing: 64] [Article Influence: 3.8] [Reference Citation Analysis]
74 Nakagawa Y, Akao Y, Morikawa H, Hirata I, Katsu K, Naoe T, Ohishi N, Yagi K. Arsenic trioxide-induced apoptosis through oxidative stress in cells of colon cancer cell lines. Life Sci 2002;70:2253-69. [PMID: 12005185 DOI: 10.1016/s0024-3205(01)01545-4] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 3.7] [Reference Citation Analysis]
75 Récher C, Chopin M, Raffoux E, Pierron G, Poupon J, Sigaux F, Dombret H, Stern M. In vitro and in vivo effectiveness of arsenic trioxide against murine T-cell prolymphocytic leukaemia: Arsenic in T-PLL. British Journal of Haematology 2002;117:343-50. [DOI: 10.1046/j.1365-2141.2002.03421.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
76 Cheson BD, Dancey J, Murgo A. New Drugs for the Treament of Chronic Lymphocytic Leukemia. Reviews in Clinical and Experimental Hematology 2001;4:145-66. [DOI: 10.1046/j.1468-0734.2000.00011.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
77 Park JW, Choi YJ, Jang MA, Baek SH, Lim JH, Passaniti T, Kwon TK. Arsenic trioxide induces G2/M growth arrest and apoptosis after caspase-3 activation and bcl-2 phosphorylation in promonocytic U937 cells. Biochem Biophys Res Commun 2001;286:726-34. [PMID: 11520058 DOI: 10.1006/bbrc.2001.5416] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 3.6] [Reference Citation Analysis]
78 Grad JM, Bahlis NJ, Reis I, Oshiro MM, Dalton WS, Boise LH. Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells. Blood 2001;98:805-13. [PMID: 11468182 DOI: 10.1182/blood.v98.3.805] [Cited by in Crossref: 199] [Cited by in F6Publishing: 207] [Article Influence: 9.5] [Reference Citation Analysis]
79 Tallman M. Arsenic trioxide: its role in acute promyelocytic leukemia and potential in other hematologic malignancies. Blood Reviews 2001;15:133-42. [DOI: 10.1054/blre.2001.0160] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
80 Lehmann S, Bengtzen S, Paul A, Christensson B, Paul C. Effects of arsenic trioxide (As2O3) on leukemic cells from patients with non-M3 acute myelogenous leukemia: studies of cytotoxicity, apoptosis and the pattern of resistance. Eur J Haematol 2001;66:357-64. [PMID: 11488934 DOI: 10.1034/j.1600-0609.2001.066006357.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.2] [Reference Citation Analysis]
81 Sordet O, Rébé C, Leroy I, Bruey JM, Garrido C, Miguet C, Lizard G, Plenchette S, Corcos L, Solary E. Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis. Blood. 2001;97:3931-3940. [PMID: 11389037 DOI: 10.1182/blood.v97.12.3931] [Cited by in Crossref: 70] [Cited by in F6Publishing: 72] [Article Influence: 3.3] [Reference Citation Analysis]
82 Iwama K, Nakajo S, Aiuchi T, Nakaya K. Apoptosis induced by arsenic trioxide in leukemia U937 cells is dependent on activation of p38, inactivation of ERK and the Ca2+-dependent production of superoxide. Int J Cancer. 2001;92:518-526. [PMID: 11304686 DOI: 10.1002/ijc.1220] [Cited by in Crossref: 93] [Cited by in F6Publishing: 97] [Article Influence: 4.4] [Reference Citation Analysis]
83 Maruyama W, Akao Y, Youdim MB, Naoi M. Neurotoxins induce apoptosis in dopamine neurons: protection by N-propargylamine-1(R)- and (S)-aminoindan, rasagiline and TV1022. J Neural Transm Suppl 2000;:171-86. [PMID: 11205138 DOI: 10.1007/978-3-7091-6301-6_11] [Cited by in Crossref: 7] [Cited by in F6Publishing: 17] [Article Influence: 0.3] [Reference Citation Analysis]
84 Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Willman C, Bloomfield CD, Rowe JM, Wiernik PH. All-Trans-Retinoic Acid Maintenance for Acute Promyelocytic Leukemia. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion 2001. [DOI: 10.1007/978-3-642-18156-6_90] [Reference Citation Analysis]
85 Hossain K, Akhand AA, Kato M, Du J, Takeda K, Wu J, Takeuchi K, Liu W, Suzuki H, Nakashima I. Arsenite induces apoptosis of murine T lymphocytes through membrane raft-linked signaling for activation of c-Jun amino-terminal kinase. J Immunol. 2000;165:4290-4297. [PMID: 11035063 DOI: 10.4049/jimmunol.165.8.4290] [Cited by in Crossref: 87] [Cited by in F6Publishing: 92] [Article Influence: 4.0] [Reference Citation Analysis]
86 Naoi M, Maruyama W, Akao Y, Zhang J, Parvez H. Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopamine neurons. Toxicology 2000;153:123-41. [DOI: 10.1016/s0300-483x(00)00309-7] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
87 Kitamura K, Minami Y, Yamamoto K, Akao Y, Kiyoi H, Saito H, Naoe T. Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis. Leukemia 2000;14:1743-50. [DOI: 10.1038/sj.leu.2401900] [Cited by in Crossref: 88] [Cited by in F6Publishing: 88] [Article Influence: 4.0] [Reference Citation Analysis]
88 Zhang T, Westervelt P, Hess JL. Pathologic, Cytogenetic and Molecular Assessment of Acute Promyelocytic Leukemia Patients Treated with Arsenic Trioxide (As2O3). Mod Pathol 2000;13:954-61. [DOI: 10.1038/modpathol.3880174] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
89 Huang S, Huang CF, Lee T. Induction of mitosis-mediated apoptosis by sodium arsenite in HeLa S3 cells. Biochemical Pharmacology 2000;60:771-80. [DOI: 10.1016/s0006-2952(00)00397-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 1.2] [Reference Citation Analysis]
90 Roboz GJ, Dias S, Lam G, Lane WJ, Soignet SL, Warrell RP, Rafii S. Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis. Blood 2000;96:1525-30. [DOI: 10.1182/blood.v96.4.1525] [Cited by in Crossref: 191] [Cited by in F6Publishing: 188] [Article Influence: 8.7] [Reference Citation Analysis]
91 Roboz GJ, Dias S, Lam G, Lane WJ, Soignet SL, Warrell RP, Rafii S. Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis. Blood 2000;96:1525-30. [DOI: 10.1182/blood.v96.4.1525.h8001525_1525_1530] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
92 Tu SP, Zhong J, Tan JH, Jiang XH, Qiao MM, Wu YX, Jiang SH. Induction of apoptosis by arsenic trioxide and hydroxy camptothecin in gastriccancer cells in vitroWorld J Gastroenterol 2000; 6(4): 532-539 [PMID: 11819642 DOI: 10.3748/wjg.v6.i4.532] [Cited by in F6Publishing: 22] [Reference Citation Analysis]
93 Alemany M, Levin J. The effects of arsenic trioxide (As2O3) on human megakaryocytic leukemia cell lines. With a comparison of its effects on other cell lineages. Leuk Lymphoma 2000;38:153-63. [PMID: 10811458 DOI: 10.3109/10428190009060329] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 1.2] [Reference Citation Analysis]
94 Akao Y, Yamada H, Nakagawa Y. Arsenic-induced apoptosis in malignant cells in vitro. Leuk Lymphoma. 2000;37:53-63. [PMID: 10721769 DOI: 10.3109/10428190009057628] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 2.5] [Reference Citation Analysis]
95 West RR, Stafford DA, White AD, Bowen DT, Padua RA. Cytogenetic abnormalities in the myelodysplastic syndromes and occupational or environmental exposure. Blood 2000;95:2093-7. [DOI: 10.1182/blood.v95.6.2093] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 2.5] [Reference Citation Analysis]
96 Cai X, Shen YL, Zhu Q, Jia PM, Yu Y, Zhou L, Huang Y, Zhang JW, Xiong SM, Chen SJ. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia. Leukemia. 2000;14:262-270. [PMID: 10673743 DOI: 10.1038/sj.leu.2401650] [Cited by in Crossref: 193] [Cited by in F6Publishing: 196] [Article Influence: 8.8] [Reference Citation Analysis]
97 Seol JG, Park WH, Kim ES, Jung CW, Hyun JM, Kim BK, Lee YY. Effect of arsenic trioxide on cell cycle arrest in head and neck cancer cell line PCI-1. Biochem Biophys Res Commun. 1999;265:400-404. [PMID: 10558879 DOI: 10.1006/bbrc.1999.1697] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 2.5] [Reference Citation Analysis]
98 Jing Y, Dai J, Chalmers-redman RM, Tatton WG, Waxman S. Arsenic Trioxide Selectively Induces Acute Promyelocytic Leukemia Cell Apoptosis Via a Hydrogen Peroxide-Dependent Pathway. Blood 1999;94:2102-11. [DOI: 10.1182/blood.v94.6.2102] [Cited by in Crossref: 397] [Cited by in F6Publishing: 396] [Article Influence: 17.3] [Reference Citation Analysis]
99 Jing Y, Dai J, Chalmers-redman RM, Tatton WG, Waxman S. Arsenic Trioxide Selectively Induces Acute Promyelocytic Leukemia Cell Apoptosis Via a Hydrogen Peroxide-Dependent Pathway. Blood 1999;94:2102-11. [DOI: 10.1182/blood.v94.6.2102.418k29_2102_2111] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 1.2] [Reference Citation Analysis]
100 Akao Y, Nakagawa Y, Akiyama K. Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro. FEBS Lett. 1999;455:59-62. [PMID: 10428472 DOI: 10.1016/s0014-5793(99)00841-8] [Cited by in Crossref: 126] [Cited by in F6Publishing: 131] [Article Influence: 5.5] [Reference Citation Analysis]
101 Larochette N, Decaudin D, Jacotot E, Brenner C, Marzo I, Susin SA, Zamzami N, Xie Z, Reed J, Kroemer G. Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore. Exp Cell Res. 1999;249:413-421. [PMID: 10366441 DOI: 10.1006/excr.1999.4519] [Cited by in Crossref: 213] [Cited by in F6Publishing: 220] [Article Influence: 9.3] [Reference Citation Analysis]
102 Akao Y, Nakagawa Y, Maruyama W, Takahashi T, Naoi M. Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, is mediated by activation of caspase 3. Neuroscience Letters 1999;267:153-6. [DOI: 10.1016/s0304-3940(99)00361-4] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 1.6] [Reference Citation Analysis]
103 Chen G, Cai X, Shen Y, Zhou L, Zhu Q, Yu Y, Jia P, Zhu X, Chen S, Wang Z, Chen Z. Cellular and molecular mechanism of arsenic trioxide in the treatment of hematopoietic malignancies. CJIM 1999;5:82-88. [DOI: 10.1007/bf02934648] [Reference Citation Analysis]